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物载体而受到热捧，而目前对于合成 nm 级的，尤其是 300 nm 以下的聚多巴胺胶
囊还比较难，而对其光热治疗，光声成像方面的研究也较少。 







μg/mL 样品溶液在经 808 nm 激光照射 5 min 后，温度从 23.3°C 升高到 66.3°C，
远超细胞的耐受温度 50°C，而作为对照的溶剂在相同条件下，温度仅升高了 4°C。
经过计算，该 PDA 胶囊的光热转换效率达到 38.75%，远超其他的光热治疗材料，
如金纳米棒（22%）。体内外实验显示，PDA 胶囊对细胞没有明显毒性，生物相
容性良好，利用激光照射引起的光热效应能够有效抑制 MCF-7 细胞活力，尤其是
在 200 μg/mL 时，细胞相对存活率锐减至 16.6%左右。在小鼠实验中，PDA 胶囊
组在激光照射下也可成功抑制肿瘤生长。在光声成像方面，相同大小的 PDA 胶
囊和 PDA 实心纳米粒子都能产生较强的光声信号。但与 PDA 实心纳米粒子相比，
相同浓度下，PDA 胶囊的信号甚至超过了实心纳米粒子的两倍。为了能够更彻底












































Cancer is one of the biggest challenges that human face today in health, and its 
treatment has always been a very important issue, which included the basic method of 
chemotherapy, surgical resection and the emerging method of gene therapy, 
photothermal therapy, photodynamic therapy. With the continuous improvement of 
nanotechnology, the concept of theranostic has introduced recently, which aimed at the 
early detection and early treatment, to improve the cure rate greatly. Polydopamine has 
aroused widely attention since its discovery, because of its biocompatibility, and has 
broad spectrum absorption and other characteristics. Polydopamine capsules was 
considered as drug delivery vehicles when it was first prepared. And it is still difficult 
to prepare the PDA capsules with the nanometer diameter, especially the size is below 
300 nm. Moreover, there is few literature about its photothermal effect and 
photoacoustic imaging. 
In this paper, an improved DMDES emulsion template method was used to 
synthesize the polydopamine (PDA) hollow capsules with the size of 200 nm. Then, 
the photothermal effect and photoacoustic imaging ability of the PDA capsules in vitro 
and in vivo were investigated and compared with the same size of PDA particles. In 
addition, to kill cancer cells more completely, PDA capsules, which was usually as a 
common drug carrier, was loaded with DOX, a model anticancer drug. Its synergistic 
effect of chemotherapy and photothermal chemotherapy was proceeded to investigate. 
The results showed that the prepared PDA capsules were stable in aqueous 
solution and with uniform size. Similar to other polydopamine materials, it has a strong 
absorption in the near infrared region, so it has a good photothermal effect. After PDA 
capsule solution (200 μg/mL) was exposed to 808 nm laser irradiation for 5 min, the 
temperature was increased to 63.3°C - much greater than 50°C, a tolerance temperature 
of the cancer cell. While the temperature of the solvent, a control group was only 



















(η) of PDA capsule was calculated to be 38.75%, which was far greater than other 
materials used for photothermal therapy, such as gold nanorods (22%). And the results 
of photothermal therapy in vivo are in accordance with the in vitro. There was no 
obvious toxicity observed when the PDA capsules were incubated with the cells alone, 
which indicated the good biocompatibility. However, the photothermal effect was 
significant with the irradiation as it can inhibit the viability of MCF-7 cells, especially 
at 200 μg/mL, the cell survival rate was dropped to 16.6%. Furthermore, the 
photothermal effect can also inhibit the growth of tumor in the tumor-bearing mice. On 
the other hand, photoacoustic imaging of PDA capsules has also been shown to be 
effective, both in vitro and in vivo, which was far stronger than the PDA nanoparticles 
under the same conditions. In vitro, the signal of PDA capsule was over two folders 
than the PDA nanoparticles at the same concentration. Moreover, the signal of them 
was both far outweigh the control group. And the in vivo experiment exhibited the 
same result. In order to treat cancer more thoroughly, we successfully loaded DOX on 
PDA capsules by π-π stack or (and) electrostatic force, and its photothermal effect and 
photoacoustic imaging ability did not influenced by drug loading. In addition, the 
delivery system could be uptaken by cells, and deliver the drug to the corresponding 
position to have a certain inhibitory effect. With the photothermal effect of PDA 
capsules, the nanosystem can inhibit the tumor growth greatly whether at the cellular 
level or animal level. 
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计，2012 年癌症共造成全球 820 万人死亡，而这一数值还在不断递增，到 2015 年
时已达到 880 万人。另外随着患癌率的提升，死亡率也可能继续升高，2012 年有
1400 万新增癌症患者[1]，今后二十年新发病例数将增加约 70%[2]。我国的癌症形势
也日益严峻。调查发现，近 20 年来，癌症的发病情况呈现逐渐年轻化态势，且发











射线计算机断层扫描（X-ray computerized tomography，CT）、超声成像（ultrasound 























CT 成像是在传统的 X 射线成像的基础上发展起来的，主要是通过测定 X 射线
在人体内的衰减系数，然后经计算机处理再重建断层图像的过程[8]。它的扫描速度
较快，对组织密度的分辨能力较高，可以直接观察到脏器内部的病变情况。另外，
因为 X 射线对骨骼的穿透性较强，是以 CT 成像可以更加切确地诊断颅内肿瘤。但
X 射线所产生的电离辐射对人体的伤害较大，而且不能很好地分辨软组织，需要
CT 造影剂的协助，最常用的是碘海醇（iohexol，三碘三酰胺六醇苯）成为现在临









































图 1-1 常见成像仪器及代表性图像[19-21] 
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